Palatin Technologies Sells Vyleesi in $171M Transaction
December 21, 2023
New York, December 21, 2023 – Palatin Technologies, Inc. (NYSE American: PTN) has completed the sale of Vyleesi® to Cosette Pharmaceuticals, a US-based, specialty pharmaceutical company, for up to